GSH-responsive magnetic imaging for <i>in situ</i> monitoring of tumor chemodynamic therapy

Chemodynamic therapy (CDT) is a promising treatment modality that utilizes highly toxic hydroxyl radicals (˙OH) to kill tumor cells <i>in situ</i>. However, real-time monitoring of drug distribution and therapeutic response remains a challenge, hindering the optimization of personalized treatment regimens. Here, we developed a glutathione (GSH)-responsive nanoreactor (FA-Mn NR), with integrated magnetic resonance imaging (MRI) functionality for self-enhanced CDT. The nanoreactor undergoes GSH-triggered Mn<sup>2+</sup> release, which simultaneously functions as an MRI contrast agent and catalyzes hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) to produce additional ˙OH, thereby achieving synergistic CDT amplification. The study demonstrates a theranostic platform combining GSH-responsive imaging guidance with enhanced therapeutic efficacy, presenting a novel approach for cancer therapy.

Authors

Institutions

Publication Details

Journal
Chemical Science
Published
2025-01-01
DOI
https://doi.org/10.1039/d5sc04436g
Citations
3
Primary Topic
Advanced MRI Techniques and Applications
Type
article
Field-Weighted Citation Impact
4.08

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GSH-responsive magnetic imaging for in situ monitoring of tumor chemodynamic therapy

Wei Zhang, Jun Lu, Zhongyao Jiang, Yue‐Qin Tang et al.
3 citations
Chemical Science
Advanced MRI Techniques and Applications
4.08
article

GSH-responsive magnetic imaging for in situ monitoring of tumor chemodynamic therapy

Wei Zhang, Jun Lu, Zhongyao Jiang, Yue‐Qin Tang, Ping Li, Wen Zhang, Hui Wang, Bo Tang, Xinyu Chen
article en
3 citations

Abstract

Chemodynamic therapy (CDT) is a promising treatment modality that utilizes highly toxic hydroxyl radicals (˙OH) to kill tumor cells <i>in situ</i>. However, real-time monitoring of drug distribution and therapeutic response remains a challenge, hindering the optimization of personalized treatment regimens. Here, we developed a glutathione (GSH)-responsive nanoreactor (FA-Mn NR), with integrated magnetic resonance imaging (MRI) functionality for self-enhanced CDT. The nanoreactor undergoes GSH-triggered Mn<sup>2+</sup> release, which simultaneously functions as an MRI contrast agent and catalyzes hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) to produce additional ˙OH, thereby achieving synergistic CDT amplification. The study demonstrates a theranostic platform combining GSH-responsive imaging guidance with enhanced therapeutic efficacy, presenting a novel approach for cancer therapy.

Chemical ScienceVol. 16(38)
Shandong Normal University (CN), Qilu Hospital of Shandong University (CN), Laoshan Laboratory
National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Government of Shandong Province
Openalex Percentile: Top 6%
Advanced MRI Techniques and Applications
4.08
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

GSH-responsive magnetic imaging for <i>in situ</i> monitoring of tumor chemodynamic therapy — Wei Zhang, Jun Lu, et al. · Chemical Science (2025) | TGRS Research Map | TGRS